This could be a consequence of genetic alterations in enzymes regulating epigenetic patterns, such as gene mutations found in human myeloid malignancies, including DNMT3a, TET2, IDH1, IDH2, EZH2, or ASXL1[53]. This evidence concerns the gene TET2 and cancer.